547 related articles for article (PubMed ID: 33971585)
1. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
J Autoimmun; 2021 Jun; 120():102644. PubMed ID: 33971585
[TBL] [Abstract][Full Text] [Related]
2. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
bioRxiv; 2021 Feb; ():. PubMed ID: 33655248
[TBL] [Abstract][Full Text] [Related]
3. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
Wang JY; Zhang W; Roehrl VB; Roehrl MW; Roehrl MH
Front Immunol; 2022; 13():831849. PubMed ID: 35401574
[TBL] [Abstract][Full Text] [Related]
4. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
Wang JY; Zhang W; Roehrl VB; Roehrl MW; Roehrl MH
bioRxiv; 2021 Apr; ():. PubMed ID: 33851168
[TBL] [Abstract][Full Text] [Related]
5. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19.
Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
bioRxiv; 2021 Jul; ():. PubMed ID: 34729561
[TBL] [Abstract][Full Text] [Related]
6. A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases.
Wang JY; Roehrl MW; Roehrl VB; Roehrl MH
J Transl Autoimmun; 2022; 5():100147. PubMed ID: 35237749
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
Front Immunol; 2021; 12():686462. PubMed ID: 34276672
[TBL] [Abstract][Full Text] [Related]
8. An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
bioRxiv; 2021 Jan; ():. PubMed ID: 33501444
[TBL] [Abstract][Full Text] [Related]
9. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V
Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
[TBL] [Abstract][Full Text] [Related]
10. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.
Wang JY; Roehrl MW; Roehrl VB; Roehrl MH
bioRxiv; 2021 Aug; ():. PubMed ID: 34373855
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.
Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M
Front Immunol; 2022; 13():945021. PubMed ID: 36032086
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins.
Zhang W; Rho JH; Roehrl MH; Wang JY
BMC Immunol; 2019 Jun; 20(1):21. PubMed ID: 31242852
[TBL] [Abstract][Full Text] [Related]
13. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
[TBL] [Abstract][Full Text] [Related]
15. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
[TBL] [Abstract][Full Text] [Related]
16. The intersection of COVID-19 and autoimmunity.
Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
18. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
Front Immunol; 2022; 13():732197. PubMed ID: 35154090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
